fbpx

Green Tea Extract shrinks Uterine Fibroids

Share Button

fibroid volume increased (24.3%) over the study period; however, patients randomized to green tea extract treatment showed significant reduction (32.6%) in total UF volume

As a long-term cancer survivor I research and write about cancer, its causes, its symptoms and most of all, how to cure it.

 

A frequently asked about cause of cancer on PeopleBeatingCancer is uterine fibroids (UF) aka endometrial polyps (EP).  I posted a study that determined the average risk that UF/EP is cancerous is 2.5%.

While the possibility of a malignant (cancerous) polyps are on everyone’s mind, judging by the comments written after my post, there are a great many challenges that women who are diagnosed with UF/EP face including anemia, bleeding and the reduced chances of pregnancy. If you are a woman who has been diagnosed with UF/EP please consider the study’s findings below:

  • Green Tea Extract (epigallocatechin gallate [EGCG])  showed significant reduction in total UF volume-
  • Anemia also significantly improved by 0.7 g/dL in the EGCG treatment group, while average blood loss significantly decreased from 71 mL/month to 45 mL/month-
  • No adverse effects, endometrial hyperplasia, or other endometrial pathology were observed in either group-

I take Green Tea extract to reduce the risk of many cancers including my own, multiple myeloma. The brand I take, Life Extension Foundation Mega Green Tea Extract contains the greatest amount of EGCG per capsule (326.25mg) supplement of the brands tested by ConsumerLab.com. (you must be a member to view this study). Good Luck.

For any other questions or comments about nutritional supplementation to manage cancer, scroll down the page, post a question or comment and I will reply ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:


Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study.

BACKGROUND: Uterine fibroids (UFs, also known as leiomyoma) affect 70% of reproductive-age women. Imposing a major burden on health-related quality-of-life (HRQL) of premenopausal women, UF is a public health concern. There are no effective medicinal treatment options currently available for women with symptomatic UF…

OBJECTIVES: To evaluate the efficacy and safety of green tea extract (epigallocatechin gallate [EGCG]) on UF burden and quality of life in women with symptomatic UF, in a double-blinded, placebo-controlled randomized clinical trial…

RESULTS: Of the final 39 women recruited for the study, 33 were compliant and completed all five visits of the study. In the placebo group (n = 11), fibroid volume increased (24.3%) over the study period; however, patients randomized to green tea extract (n = 22, 800 mg/day) treatment showed significant reduction (32.6%, P = 0.0001) in total UF volume. In addition, EGCG treatment significantly reduced fibroid-specific symptom severity (32.4%, P = 0.0001) and induced significant improvement in HRQL (18.53%, P = 0.01) compared to the placebo group. Anemia also significantly improved by 0.7 g/dL (P = 0.02) in the EGCG treatment group, while average blood loss significantly decreased from 71 mL/month to 45 mL/month (P = 0.001). No adverse effects, endometrial hyperplasia, or other endometrial pathology were observed in either group.

CONCLUSION: EGCG shows promise as a safe and effective therapeutic agent for women with symptomatic UFs. Such a simple, inexpensive, and orally administered therapy can improve women’s health globally.”

Leave a Comment:

11 comments
Add Your Reply